A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

June 4, 2025

Study Completion Date

December 31, 2025

Conditions
Eosinophilic Esophagitis
Interventions
BIOLOGICAL

barzolvolimab

subcutaneous administration

DRUG

Matching Placebo

subcutaneous administration

Trial Locations (45)

10016

NYU Langone Health, New York

17033

The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center, Hershey

19104

University of Pennsylvania, Philadelphia

27514

University of North Carolina (UNC) Hospitals, Chapel Hill

27710

Duke University Medical Center, Durham

32256

ENCORE Borland Groover Clinical Research, Jacksonville

32763

Gastroenterology of Greater Orlando, Orange City

35209

AllerVie Clinical Research, Birmingham

37232

Vanderbilt University Medical Center-GI Clinical Research Program, Nashville

44096

The Clinical Trials Network, LLC, Willoughby

52242

University of Iowa, Iowa City

60208

Northwestern University, Chicago

66160

University of Kansas Medical Center (KUMC), Kansas City

70072

Tandem Clinical Research, Marrero

83706

Treasure Valley Medical Research, Boise

84124

Care Access Research, Salt Lake City

84132

University of Utah, Salt Lake City

84405

Advanced Research Institute - Ogden, Ogden

85258

One of a Kind Clinical Research Center, Scottsdale

85351

GI Alliance- Arizona Digestive Health- Sun City, Sun City

85715

Del Sol Research Management, LLC, Tucson

91910

GW Research Inc., Chula Vista

06416

Connecticut Clinical Research Institute, LLC, Bristol

02111

Boston Specialists - Boston Food Allergy Center, Boston

Unknown

Royal Adelaide Hospital, Adelaide

The Alfred Hospital, Melbourne

St Vincent's Hospital Melbourne, Melbourne

University of Calgary, Calgary

PerCuro Clinical Research Ltd., Victoria

Universitaetsklinikum Augsburg, Augsburg

Klinikum Region Hannover GmbH Burgwedel, Hanover

Universitaetsklinikum Magdeburg A.oe.R., Magdeburg

IRCCS Ospedale San Raffaele, Milan

Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Rome

Istituto Clinico Humanitas, Rozzano

"Azienda Ospedaliera Universitaria OO.RR. San Giovanni di Dio Ruggi d'Aragona-Plesso Ruggi", Salerno

Azienda Ospedaliera - Universitaria Integrata di Verona - Ospedale Borgo Roma, Verona

Centrum Medyczne Med-Gastr Sp. z o.o., Lodz

WIP Warsaw IBD Point Profesor Kierkus, Warsaw

Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy, Klinika Gastroenterologii i Chorob, Warsaw

Hospital General Universitario de Alicante Dr. Balmis, Alicante

Hospital Clinico San Carlos, Madrid

St George's Hospital, London

St. Thomas' Hospital, London

Norfolk and Norwich University Hospital, Norwich

Sponsors
All Listed Sponsors
lead

Celldex Therapeutics

INDUSTRY